Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue

Immunotherapy,Volume 11, Issue 5, Page 365-368, April 2019.

Source: Immunotherapy - February 21, 2019 Category: Allergy & Immunology Authors: Giandomenico Roviello Daniele Generali Anna Ianza Source Type: research